Overview

James in an experienced corporate finance lawyer, qualified in 2000.

James is a partner in our Corporate practice, based in Hong Kong.

He specialises in corporate finance and has advised sponsors and issuers on a number of Hong Kong IPOs and debt capital market transactions.  

Throughout his career, he has also advised on different types of corporate finance matters including share placement, rights issue, takeovers, private equities, listing of exchange traded funds, cash offers, joint ventures and regulatory compliance.

James joined us this year, having previously worked at two global law firms.  He was admitted as a solicitor in Hong Kong in 2000 and England and Wales in 2001.

He is fluent in English, Cantonese and Mandarin.

Sector and Practice Information

Corporate

News & Events

  1. 1007-2019

    Cybersecurity & Singapore - Mitigating risks posed by digitalised payments

    Given increased adoption of new technology for payment systems and within the financial ecosystem, the relevant authorities in Singapore have provided guidelines to mitigate cybersecurity risks. Despite adopting ...

  2. 0207-2019

    Cybersecurity & Singapore - Disclosures for Listed Companies

    With the spate of cybersecurity incidents on large listed companies, cybersecurity risk has increasingly become a key point that affects investor risk appetite and companies are now subject to certain disclosure ...

  3. 2706-2019

    Bird & Bird assists Addtech Group with the acquisition of Thiim A/S

    Bird & Bird assisted the Swedish Addtech Group during the M&A process of all shares outstanding in the Danish company Thiim A/S on 12 June 2019.

  1. 2706-2019

    Bird & Bird team up with more than 10 law firms to scale up solar power

    International law firm Bird & Bird teamed up with more than 10 law firms to scale up solar power as part of the Open Solar Contracts initiative, launched on 13 June 2019 at the African Energy Forum in Lisbon, Portugal

  2. 3005-2019

    International team advises Chiesi Farmaceutici on in-licence of Raxone® from Santhera

    International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")

  3. 2405-2019

    Bird & Bird advises FUJIFILM on the 100% acquisition of medwork

    International law firm Bird & Bird advises the FUJIFILM group on the acquisition of German medwork GmbH, a company that develops, manufactures and markets instruments for therapeutic and diagnostic endoscopy.

View More Firm News

There are no forthcoming events for this area. Please click on the button below to view past events.

View more events
  1. 1202-2019

    Setting up a business in Hong Kong

    Hong Kong is a welcoming environment to foreign investors. Bank accounts may be held in any foreign currency and there are no specific laws governing inward investment. Hong Kong’s access to the markets in Mainland ...

  2. 0612-2018

    Setting up a business in Hong Kong

    Hong Kong is a welcoming environment to foreign investors. Bank accounts may be held in any foreign currency and there are no specific laws governing inward investment.

  3. 0907-2018

    HKEx issued new consultation paper on backdoor listing and continuing listing criteria

    On 29 June 2018, the Stock Exchange of Hong Kong Limited ("HKEx") published the Consultation Paper on Backdoor Listing...

Talk to an expert
Find a contact

Not sure who to contact

Select a sector or practice area then optionally filter by a location

OR

Email
 
Know who you're looking for?

Select a sector, practice area or hot topic then optionally filter by a location and/or position:

OR